Affiliation:
1. Division of Vascular and Interventional Radiology, Department of Radiology, The Ohio State University Medical Center, Columbus, OH 43210, USA
Abstract
A large majority of primary hepatobiliary tumors are hepatocellular carcinomas (HCC), with the remainer being cholangiocarcinoma. While surgical resection remains the gold standard treatment for hepatobiliary tumors, relatively few patients are operative candidates, and systemic treatments have limited effectiveness. Locoregional therapies offer significant promise in the management of HCC. Ablation and radioembolization may offer similar outcomes to surgery for early-stage hepatocellular carcinoma while radioembolization and chemoembolization are valuable in the management of advanced disease. There is significantly less evidence for the role of locoregional therapy in the treatment of cholangiocarcinoma, although it appears to be well tolerated.
Reference54 articles.
1. Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers Version 2.2014;Benson;J. Natl. Comp. Cancer Netw.,2014
2. BCLC Strategy for Prognosis, Prediction, and Treatment Recommendation: The 2022 Update;Reig;J. Hepatol.,2022
3. Sotiros, V., and Soulen, M. (2021). Image-Guided Interventions, Elsevier. [3rd ed.].
4. European Association for the Study of the Liver (2018). EASL Clinical Practice Guideline: Management of Hepatocellular Carcinoma. J. Hepatol., 69, 182–236.
5. AASLD Practice Guidance on Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma;Singal;Hepatology,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献